| Fund ID | 805-2960776103 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | Yes |
| % of assets independently valued | 7% |
| Owned by the adviser or related persons | 13% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 97% |
| Fund | Type | Gross assets |
|---|---|---|
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | Private Equity | $266.5M |
| Ally Bridge Group Capital Partners II, L.P. | Private Equity | $132.9M |
| Ally Bridge Group Innovation Capital Partners III, L.P. | Private Equity | $14.3M |
Ally Bridge Group-Wtt Global Life Science Capital Partners, L.P. reports $616.3 million in gross assets, among the top 11% of private funds by size.
The stated minimum investment is $100,000.
Ally Bridge Group-Wtt Global Life Science Capital Partners, L.P. is managed by Ally Bridge Group (pe) LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.